DTC "Brief Summary" Should Refer To Other Treatment Options, Blues Tell FDA
This article was originally published in The Pink Sheet Daily
Executive Summary
Prescribing information for direct-to-consumer ads should include a tagline encouraging consumers to consult their doctors for other treatment options, the Blue Cross/Blue Shield Association comments on FDA's DTC draft guidances say.